Optimize the development of biologics through the application of computational tools. Discover how Merck, Pfizer, BMS and Abbvie have used computational approaches to add significant value.
Computational tools have the ability to add tangible value to the development of biologic drugs. When utilized effectively, computational techniques can shorten timelines and enhance the cost-effectiveness of biologic drug development.
Computational Drug Development 2016 will bridge the gap between the application of computational tools for small molecule and biologic drug development. This meeting will bring together leading computational scientists from pharma, biotech, academia and software companies to evolve new solutions to focus the growing computational power on the richly accessible information generated in discovery and development.
URLs:
Brochure: https://go.evvnt.com/71044-0
Booking: https://go.evvnt.com/71044-1
Website: https://go.evvnt.com/71044-2
Prices:
Industry - Conference + 2 Workshops: USD 3797,
Industry - Conference + 1 Workshop: USD 3198,
Industry - Conference Only: USD 2699,
Industry - Workshop Only: USD 699,
Academic - Conference + 2 Workshops: USD 2397,
Academic - Conference + 1 Workshop: USD 1998,
Academic - Conference Only: USD 1599,
Academic - Workshop Only: USD 499
Speakers: Sandeep Kumar Head, Molecular Modeling, Simulations and Data Analyses Center of Emphasis, Biotherapeutics Pharmaceutical Sciences, Pfizer, Joseph Audie CEO and CSO CMDBioscience, Chris Bailey-Kellog Professor Dartmouth College, Rafael Depetris Director Molecular Oncology Kadmon Pharmaceuticals, Surjit Dixit CTO Zymeworks, Feng Dong Senior Scientist Abbvie, Sookhee Ha Senior Research Fellow Merck, Christine Hajdin Investigator Novartis, Philip Kim Associate Professor University of Toronto, Stanley Krystek Senior Principal Scientist Bristol-Myers Squibb, Michelle Lynn Hall Senior Scientist Computational Chemistry Moderna Therapeutics, Eliud Oloo Manager Structure Genomics and Bioinformatics Sanofi Pasteur Biologics, Deepangi Pandit Scientist ll Cell Signalling Technology, Enrico Purisima Team Leader Molecular Modeling NRC Canada, Dominic Ryan Independent Consultant, Brad Sherborne Director Computer-Aided Drug Design Merck, Arvind Sivasubramanian Senior Scientist Computational Biology, Adimab Vanita Sood Global Head of Drug Structure Prediction and Design EMD, Serono Jeffrey Way Senior Staff Scientist Wyss Institute Harvard University
Date and Time: On Tuesday December 13, 2016 at 7:30 am to Thursday December 15, 2016 at 4:15 pm
Venue details: Aloft Seaport Boston, 401-403 D St, Boston, MA, 02210, United States
